文献速递功能神经外科

微血管减压术治疗三叉神经痛中血管移位法与间置法的比较:单中心两种技术的中期分析

Transposition versus interposition method in microvascular decompression for trigeminal neuralgia: midterm analysis of both techniques in a single-center study.
PubMed 文献 · J Neurosurg · 2024-01-26

该单中心回顾性研究分析了2008至2022年间接受微血管减压术的耐药性三叉神经痛患者,比较血管移位法(114例)与间置法(110例)的短期和中期结局。出院时移位组92.1%、间置组94.5%患者结局良好,随访时分别为83.3%和85%;移位法未能证实可改善复发预防和减少三叉神经并发症的主要目标。

要点

  • 出院时良好结局(BNI I-III级):移位组92.1% vs 间置组94.5%。
  • 随访时良好结局:移位组83.3% vs 间置组85%。
  • 复发率:移位组4.9% vs 间置组6%;并发症:24.6% vs 27.3%。

核心结论

  • 移位法微血管减压术是解决桥小脑角血管神经冲突的优雅方式,与间置法类似,在耐药性三叉神经痛患者中显示出良好的短期和中期结局。
  • 然而,移位法的主要目标——改善复发预防和减少三叉神经并发症——在本研究中未能得到证实。

研究设计与样本

  • 单中心回顾性分析,纳入2008至2022年间在该机构因耐药性三叉神经痛接受微血管减压术的所有患者。
  • 移位组114例,间置组110例;移位组102例随访中位31.5个月,间置组100例随访中位95个月。
  • 结局采用Barrow神经学研究所疼痛强度评分评估,并评估并发症和疼痛复发。

主要发现

  • 出院时良好结局(BNI疼痛强度评分I-III级):移位组92.1% vs 间置组94.5%。
  • 随访时良好结局:移位组83.3% vs 间置组85%。
  • 疼痛复发:移位组4.9% vs 间置组6%。
  • 并发症:移位组24.6% vs 间置组27.3%;最常见为面部感觉减退(移位组10.5% vs 间置组11.8%),其次为脑脊液漏(移位组2.6% vs 间置组8.2%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Operative interposition of material between the trigeminal nerve and offending artery for surgical treatment of drug-resistant trigeminal neuralgia (TGN), following the Jannetta method, has been proven to be the most successful invasive treatment. Reexplorations of patients with recurrence of TGN have revealed nerve root irritations and scarring due to interposed material. To prevent these complications, modifications of microvascular decompression (MVD) aim at transposing the vessel away from the trigeminal nerve, without attachment of additional material to the nerve root. Given that both techniques (interposition and transposition) have been performed in the authors' institution, they decided to analyze them for the short- and midterm outcomes. METHODS: All patients who had undergone MVD for drug-resistant TGN in the authors' institution between 2008 and 2022 were analyzed retrospectively. Outcome at discharge and follow-up was evaluated using the Barrow Neurological Institute pain intensity score. Additionally, complications and pain recurrence were assessed. RESULTS: A total of 114 patients were operated on using transposition and 110 patients were treated using interposition. For transposition 102 patients were followed up for a median of 31.5 months, and for interposition 100 patients were followed up for a median of 95 months. At discharge 92.1% versus 94.5% of patients in the transposition and interposition groups, respectively, experienced a good outcome (Barrow Neurological Institute pain intensity scores I-III). At follow-up, 83.3% versus 85% of patients in the transposition and interposition groups, respectively, continued to demonstrate a good outcome. In 4.9% of patients in the transposition group and in 6% of patients in the interposition group, recurrence of pain occurred. Complications occurred in 24.6% of patients in the transposition and in 27.3% of those in the interposition group. The most frequent complications were facial hypesthesia (10.5% vs 11.8%, transposition vs interposition), followed by CSF leaks (2.6% vs 8.2%). CONCLUSIONS: Transposition for MVD is an elegant way of solving vessel-nerve conflicts at the cerebellopontine angle. Similar to interposition, transposition shows positive short- and midterm outcomes for patients experiencing drug-resistant TGN. However, the main objective of transposition, which is improved prevention of recurrence and reduction of complications at the trigeminal nerve, could not be confirmed in this study.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Uhl C, Faraj L, Fekonja L, et al. Transposition versus interposition method in microvascular decompression for trigeminal neuralgia: midterm analysis of both techniques in a single-center study. J Neurosurg. 2024. PMID: 38277665. doi:10.3171/2023.11.JNS231658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。